Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News QuidelOrtho Corp QDEL

QuidelOrtho Corporation is engaged in vitro diagnostics, developing and manufacturing intelligent solutions. The Company sells its products directly to end users through a direct sales force and through a network of distributors, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies... see more

Recent & Breaking News (NDAQ:QDEL)

Quidel Reports Second Quarter 2015 Financial Results

Marketwired July 22, 2015

Quidel to Hold Second Quarter 2015 Financial Results Conference Call on July 22, 2015

Marketwired July 7, 2015

Quidel Receives FDA Clearance for Its New Solana(TM) Molecular System and Solana(TM) Molecular Assay for Diagnosis of Group a Streptococcal Infections

Marketwired June 23, 2015

Quidel to Present at the Goldman Sachs 36th Annual Global Healthcare Conference

Marketwired May 28, 2015

Quidel to Present at the Bank of America Merrill Lynch 2015 Health Care Conference

Marketwired April 29, 2015

Quidel Reports First Quarter 2015 Financial Results

Marketwired April 23, 2015

Quidel to Hold First Quarter 2015 Financial Results Conference Call on April 23, 2015

Marketwired April 9, 2015

Quidel Receives FDA Clearance for Its AmpliVue Trichomonas Assay: A Hand-Held Molecular Diagnostic Test for Trichomoniasis

Marketwired March 17, 2015

Quidel to Present at Upcoming Conferences

Marketwired February 24, 2015

Quidel Reports Fourth Quarter and Full Year 2014 Financial Results

Marketwired February 11, 2015

Quidel to Hold Fourth Quarter and Full Year 2014 Financial Results Conference Call on February 11, 2015

Marketwired January 28, 2015

Quidel to Present at 33rd Annual J.P. Morgan Healthcare Conference

Marketwired January 5, 2015

Quidel Receives Simultaneous FDA Clearance and CLIA Waiver for Its Sofia(R) Strep A+ Fluorescent Immunoassay (FIA) via the FDA's New Dual Submission Program

Marketwired December 17, 2014

Quidel Receives FDA Clearance for Its AmpliVue(R) Hand-Held Molecular Diagnostic Test for Bordetella Pertussis

Marketwired December 10, 2014

Quidel Announces Pricing of $150 Million Convertible Senior Notes Offering

Marketwired December 3, 2014

Quidel Announces Proposed Offering of $150 Million of Convertible Senior Notes

Marketwired December 1, 2014

Dr. Kenneth J. Widder Joins Quidel's Board of Directors

Marketwired November 18, 2014

Quidel Reports Third Quarter 2014 Financial Results

Marketwired October 21, 2014

Quidel Receives FDA Clearance for Its Lyra(TM) Molecular PCR Assay for the Detection of Human Parainfluenza Viruses (HPIV), Types 1, 2 and 3

Marketwired October 15, 2014

Quidel Receives FDA Clearance for Its Lyra(R) Molecular PCR Assay for the Detection of Adenovirus

Marketwired October 13, 2014